Makale detayı · 2020 · article
Overcoming the ChallengeIn vivo Efficacy of Miltefosine for Chronic Cutaneous Leishmaniasis
Dergi
Acta Parasitologica
ISSN1230-2821
YÖKSİS
OpenAlex
Açık erişim · green
Yıl2020
Atıf7OpenAlex
Yüzdelik%73,1
FWCI0,691,00 = dünya ortalaması
Scopus (SJR)Q4
WoS (JCR)Q3
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıACTA PARASITOLOGICA
- Katalog eşleşmesi (ISSN)Acta Parasitologica
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
7atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 8 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2023 Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition.Atıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro- In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex
- 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionAtıf 17 · OpenAlex